Wedge Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $829K | Buy |
144,710
+932
| +0.6% | +$5.34K | 0.01% | 448 |
|
|
2025
Q1 | $1.17M | Sell |
143,778
-45,007
| -24% | -$367K | 0.02% | 401 |
|
|
2024
Q4 | $1.78M | Hold |
188,785
| – | – | 0.03% | 345 |
|
|
2024
Q3 | $2.02M | Sell |
188,785
-44,264
| -19% | -$473K | 0.03% | 326 |
|
|
2024
Q2 | $2.31M | Buy |
233,049
+25,564
| +12% | +$254K | 0.04% | 297 |
|
|
2024
Q1 | $2.44M | Sell |
207,485
-16,433
| -7% | -$194K | 0.04% | 301 |
|
|
2023
Q4 | $3.18M | Sell |
223,918
-967
| -0.4% | -$13.7K | 0.06% | 275 |
|
|
2023
Q3 | $2.73M | Buy |
224,885
+30,990
| +16% | +$377K | 0.05% | 283 |
|
|
2023
Q2 | $2.44M | Sell |
193,895
-23,559
| -11% | -$296K | 0.04% | 351 |
|
|
2023
Q1 | $2.41M | Sell |
217,454
-11,426
| -5% | -$127K | 0.04% | 289 |
|
|
2022
Q4 | $2.8M | Buy |
+228,880
| New | +$2.8M | 0.05% | 287 |
|